| Vorinostat | IC50 | 34.0 [1] |
| Vorinostat | Ki | 21.0 [1] |
| Trichostatin A | IC50 | 6.0 [1] |
| Trichostatin A | Ki | 0.58 [1], 0.99 [2], 1.0 [3], 3.02 [4] |
| Tubastatin A | IC50 | 15.0 [1] |
| Tubastatin A | Ki | 3.3 [1], 7.56 [2] |
| Entinostat | IC50 | 13000.0 [1] |
| Romidepsin | IC50 | 670.0 [1] |
| Romidepsin | Ki | 9.5 [1], 10.0 [2], 300.1 [3] |
| Panobinostat | IC50 | 10.5 [1] |
| Panobinostat | Ki | 0.7 [1], 1.5 [2], 54.0 [3] |
| Tubacin | IC50 | 4.0 [1] |
| Tubacin | Ki | 0.9 [1], 16.0 [2], 142.0 [3] |
| Ricolinostat | IC50 | 4.7 [1] |
| Belinostat | IC50 | 9.85 [1], 15.0 [2], 27.0 [3], 50.0 [4] |
| Belinostat | Ki | 1.6 [1], 10.0 [2] |
| Apicidin | IC50 | 10000.0 [1] |
| Apicidin | Ki | 123.4 [1] |
| N-Hydroxy-1-(4-methoxybenzyl)-1H-indole-6-carboxamide | IC50 | 4570.0 [1] |
| Mocetinostat | IC50 | 10000.0 [1] |
| Largazole | IC50 | 165.6 [1], 340.0 [2], 1850.0 [3], 9290.0 [4], 11500.0 [5] |
| Dacinostat | IC50 | 5.93 [1], 8.3 [2] |
| Dacinostat | Ki | 9.5 [1] |
| HDAC6 Inhibitor | IC50 | 0.0 [1], 0.33 [2], 27.0 [3], 40.0 [4] |
| N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-isoquinoline-6-carboxamide | IC50 | 36.0 [1], 210.0 [2] |
| N-[[4-(Hydroxycarbamoyl)phenyl]methyl]-1-methylpyrrole-2-carboxamide | IC50 | 19.0 [1], 460.0 [2] |
| Lovastatin | IC50 | 16283.0 [1], 16285.0 [2] |
| Scriptaid | IC50 | 2.9 [1], 10.0 [2] |
| Scriptaid | Ki | 0.25 [1] |
| Tacedinaline | IC50 | 40000.0 [1], 100000.0 [2] |
| Quisinostat | IC50 | 76.8 [1] |
| Quisinostat | Ki | 16.9 [1], 350.0 [2] |
| 4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | IC50 | 10000.0 [1], 20000.0 [2] |
| Nexturastat A | IC50 | 5.02 [1], 5.2 [2] |
| Azumamide E | IC50 | 12000.0 [1], 50000.0 [2] |
| Azumamide E | Ki | 5000.0 [1] |
| Tert-butyl N-[(2S)-1-(cyclopentylamino)-1-oxo-7-sulfanylheptan-2-yl]carbamate | IC50 | 29.0 [1], 54.0 [2], 1120.0 [3] |
| CID 24857909 | IC50 | 89.0 [1], 90.0 [2] |
| CID 25023797 | IC50 | 230.0 [1] |
| CID 25023798 | IC50 | 150.0 [1], 210.0 [2] |
| N-Hydroxy-6-[(2S,5S,8S,11S)-8-(1H-indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanamide | IC50 | 31.0 [1] |
| 6-[(2S,5S,8S,11S)-2-Benzyl-8-(1H-indol-3-ylmethyl)-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]-N-hydroxyhexanamide | IC50 | 70.0 [1] |
| 6-[(2S,5S,8S,11S)-2-Methyl-11-(2-methylpropyl)-8-(naphthalen-1-ylmethyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanoic acid | IC50 | 4900.0 [1] |
| 2,2,2-Trifluoro-1-(5-(3-(methylsulfonylmethyl)-1,2,4-oxadiazol-5-yl)thiophen-2-yl)ethanone | IC50 | 230.0 [1], 320.0 [2], 640.0 [3] |
| 2,2,2-Trifluoro-1-(5-(3-(propylsulfonylmethyl)-1,2,4-oxadiazol-5-yl)thiophen-2-yl)ethanone | IC50 | 240.0 [1], 500.0 [2] |
| (3S,6S,9S,13S)-9-Methyl-13-(2-methylpropyl)-3-(naphthalen-1-ylmethyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 10000.0 [1] |
| 3-Hydroxy-1-[[4-(2-methylphenyl)phenyl]methyl]pyridine-2-thione | IC50 | 306.0 [1], 7750.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-(2-methylpropyl)-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 122.55 [1], 1217.0 [2], 1230.0 [3] |
| 5-Cyclopropyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 67.82 [1], 785.0 [2], 790.0 [3] |
| 4-[4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]-N-hydroxycyclohexane-1-carboxamide | IC50 | 48.0 [1], 3110.0 [2], 5440.0 [3] |
| 3-[[4-Ethoxy-3-(3-ethyl-1-methyl-7-oxo-6H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]methyl]-N-hydroxycyclobutane-1-carboxamide | IC50 | 91.0 [1], 126.0 [2], 143.0 [3] |
| Atorvastatin | IC50 | 14151.0 [1], 14466.0 [2] |
| Abexinostat | Ki | 17.0 [1], 20.0 [2] |
| n,n'-Dihydroxyoctanediamide | IC50 | 2030.0 [1] |
| n,n'-Dihydroxyoctanediamide | Ki | 14.5 [1] |
| Givinostat | Ki | 4.2 [1] |
| Fimepinostat | IC50 | 27.0 [1] |
| 3-Hydroxypyridine-2-thiol | IC50 | 681.0 [1] |
| Thailandepsin A | IC50 | 830.0 [1], 9900.0 [2] |
| N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide | IC50 | 4.0 [1] |
| N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide | Ki | 0.7 [1] |
| N-Hydroxy-4-phenylbutanamide | IC50 | 500.0 [1] |
| N-Hydroxy-4-phenylbutanamide | Ki | 150.0 [1] |
| 7-Mercapto-heptanoic acid phenylamide | IC50 | 19.0 [1], 74.0 [2] |
| N-Hydroxy-2,2-diphenylacetamide | IC50 | 10000.0 [1], 11000.0 [2] |
| N-(Quinolin-8-YL)-6-(2-sulfanylacetamido)hexanamide | IC50 | 21.0 [1], 95.3 [2] |
| 4-[2-[2-Hydroxyethyl(Phenyl)amino]-2-Oxidanylidene-Ethyl]-~{n}-Oxidanyl-Benzamide | IC50 | 56.0 [1] |
| N-(2-Aminophenyl)-4-[1-[2-(3-thienyl)ethyl]-1H-1,2,3-triazol-4-yl]benzamide | IC50 | 30000.0 [1], 100000.0 [2] |
| N-Hydroxy-4-methoxy-3-phenylmethoxybenzamide | IC50 | 2900.0 [1] |
| N'-Hydroxy-N-[3-(1-phenyltriazol-4-yl)phenyl]octanediamide | IC50 | 9.6 [1] |
| Largazole Thiol | IC50 | 35.0 [1], 49.0 [2] |
| Azumamide C | IC50 | 50000.0 [1] |
| Azumamide C | Ki | 2000.0 [1] |
| 6-(1-Adamantylcarbamoylamino)-N-hydroxyhexanamide | IC50 | 73.0 [1], 102.0 [2] |
| CID 24853793 | IC50 | 340.0 [1] |
| 2,2,2-Trifluoro-1-[5-(3-phenyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carbonyl)thiophen-2-yl]ethanone | IC50 | 310.0 [1] |
| N-(4-Hydroxybiphenyl-3-yl)benzamide | IC50 | 50000.0 [1] |
| (2r)-2-Amino-3-(2,4-Dichlorophenyl)-1-(1,3-Dihydro-2h-Isoindol-2-Yl)propan-1-One | IC50 | 30000.0 [1] |
| Thailandepsin B | IC50 | 1190.0 [1], 11000.0 [2] |
| (E)-N-Hydroxy-3-[2-(2-phenylethyl)-1-(2-pyrrolidin-1-ylethyl)benzimidazol-5-yl]prop-2-enamide | Ki | 20.0 [1], 20.6 [2] |
| 3-(3-Methyl-4-oxo-3,4-dihydroquinazolin-2-yl)propanoic acid | IC50 | 2300.0 [1], 3500.0 [2] |
| (2S)-N'-Hydroxy-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-N-phenyloctanediamide | IC50 | 3.0 [1], 6.0 [2] |
| (2R)-5-Oxo-N-[(2S)-1-oxo-7-sulfanyl-1-[3-(trifluoromethyl)anilino]heptan-2-yl]pyrrolidine-2-carboxamide | IC50 | 5.0 [1] |
| 3-(4-Fluorophenyl)-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide | IC50 | 758.0 [1], 760.0 [2] |
| 4-[[[4-(Dimethylamino)benzoyl]-[2-(4-methylanilino)-2-oxoethyl]amino]methyl]-N-hydroxybenzamide | IC50 | 3.0 [1], 30.0 [2] |
| CID 15984018 | IC50 | 360.0 [1] |
| Ethyl 2-(4-methoxyphenyl)-2-oxoethyl trithiocarbonate | IC50 | 1220.0 [1], 1258.93 [2] |
| (5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trione | IC50 | 28.11 [1], 42.0 [2] |
| N-Ethyl-5-(2,2,2-trifluoroacetyl)thiophene-2-carboxamide | IC50 | 310.0 [1] |
| 1-[5-(2,3-Dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one | IC50 | 130.0 [1], 200.0 [2] |
| 1-[5-(2,3-Dihydroindole-1-carbonyl)-1H-pyrrol-2-yl]-2,2,2-trifluoroethanone | IC50 | 580.0 [1], 880.0 [2] |
| 2,2,2-Trifluoro-1-(5-(3-methyl-1,2,4-oxadiazol-5-yl)thiophen-2-yl)ethanone | IC50 | 650.0 [1] |
| (6R)-6-[(1R,3As,4E,7aR)-4-[2-[(3R,5R)-3,5-dihydroxycyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-N-(2-aminophenyl)heptanamide | IC50 | 81000.0 [1], 81100.0 [2] |
| (S)-Benzyl 1-oxo-1-(4-phenylthiazol-2-ylamino)-6-(sulfamoylamino)hexan-2-ylcarbamate | IC50 | 180.0 [1] |
| 3-(4-Methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)propanoic acid | IC50 | 65000.0 [1], 70000.0 [2] |
| (3S,6S,9S,13S)-3-(1H-Indol-3-ylmethyl)-9-methyl-13-(2-methylpropyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 10000.0 [1] |
| (4S,7S,10S,13S)-7-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-10-(6-oxooctyl)-1,5,8,11-tetrazabicyclo[11.3.0]hexadecane-2,6,9,12-tetrone | IC50 | 10000.0 [1] |
| (3S,6S,9S,13S)-3-(1H-Indol-3-ylmethyl)-9,10-dimethyl-13-(2-methylpropyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 10000.0 [1] |
| 6-[(2S,5S,8S,11S)-8-(1H-Indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanoic acid | IC50 | 2300.0 [1], 2310.0 [2] |
| (2R,5S,8S,11S)-8-(1H-Indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-5-(6-oxooctyl)-1,4,7,10,14,15-hexazabicyclo[10.3.0]pentadeca-12,14-diene-3,6,9-trione | IC50 | 6100.0 [1] |